First FT: the day’s biggest stories
2月24日晚，长春高新（000661.SZ）子公司金赛药业宣布，自主研发的GenSci141软膏的临床试验申请已获得国家药监局批准。根据此前公告，GenSci141软膏是金赛药业研发的一款双氢睾酮软膏，主要以旁分泌的方式在靶组织内发挥作用，属于化学药品2.2和2.4类。该药物可用于改善因高促性腺激素性性腺功能减退症、5α-还原酶2缺乏症、雄激素合成减少的先天性肾上腺皮质增生症、特发性原因导致的儿童小阴茎。截至目前，全球尚无一款专门针对儿童小阴茎的药物，因此该软膏备受市场关注。
，详情可参考heLLoword翻译官方下载
// 易错点2：判断条件是<=（相等温度不算更高），且通过索引取温度，推荐阅读爱思助手下载最新版本获取更多信息
As a child, Kaley set up multiple accounts on both Instagram and YouTube so she could like and comment on her posts. She said she would also “buy” likes through a platform where she could like other people’s photos and get a slew of likes in return. “It made me look popular,” she said.，推荐阅读搜狗输入法2026获取更多信息